| |
| |
|
| Insider
Information: |
Chambers Rebecca |
| Relationship: |
Chief Financial Officer |
| City: |
San Jose |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
171,207 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,028,080 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
171,207 |
|
|
| Total
Value |
$3,028,080 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Outset Medical, Inc. |
OM |
Chief Financial Officer |
2021-06-24 |
13,597 |
2021-03-15 |
0 |
Premium* |
|
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
10,908 |
2021-06-21 |
0 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Chief Financial Officer |
2024-03-15 |
146,702 |
2022-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2024-04-24 |
4 |
A |
$42.41 |
$174,984 |
D/D |
4,126 |
10,908 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$21.10 |
$46,188 |
D/D |
(2,189) |
146,702 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,318 |
148,891 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2024-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
59,856 |
144,573 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2024-03-02 |
4 |
D |
$24.00 |
$146,688 |
D/D |
(6,112) |
84,717 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2023-12-02 |
4 |
D |
$26.54 |
$47,772 |
D/D |
(1,800) |
90,829 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2023-09-02 |
4 |
D |
$26.70 |
$97,508 |
D/D |
(3,652) |
92,629 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2023-06-02 |
4 |
D |
$26.72 |
$31,610 |
D/D |
(1,183) |
95,754 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,412 |
6,782 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,014 |
96,937 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
D |
$24.10 |
$65,697 |
D/D |
(2,726) |
70,923 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2022-12-02 |
4 |
D |
$29.14 |
$21,418 |
D/D |
(735) |
72,998 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2022-09-02 |
4 |
D |
$19.18 |
$57,981 |
D/D |
(3,023) |
73,733 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,404 |
76,756 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
4,370 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Financial Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,728 |
54,728 |
0 |
- |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• – – |
2021-06-24 |
4 |
AS |
$50.72 |
$848,373 |
D/D |
(16,727) |
13,597 |
0 |
% |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• – – |
2021-06-24 |
4 |
OE |
$6.25 |
$104,544 |
D/D |
16,727 |
30,324 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
|
– • – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
1,950 |
0 |
- |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• – – |
2021-05-25 |
4 |
OE |
$6.25 |
$104,544 |
D/D |
16,727 |
30,324 |
0 |
- |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• – – |
2021-05-25 |
4 |
AS |
$45.11 |
$754,535 |
D/D |
(16,727) |
13,597 |
0 |
% |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• • – |
2021-04-27 |
4 |
AS |
$56.33 |
$946,812 |
D/D |
(16,727) |
13,597 |
0 |
% |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• • – |
2021-04-27 |
4 |
OE |
$6.25 |
$104,544 |
D/D |
16,727 |
30,324 |
0 |
- |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• • – |
2021-03-25 |
4 |
AS |
$49.11 |
$835,318 |
D/D |
(16,727) |
13,597 |
0 |
% |
|
| OM |
Outset Medical, Inc. |
Chief Financial Officer |
• • – |
2021-03-25 |
4 |
OE |
$6.25 |
$104,544 |
D/D |
16,727 |
30,324 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
